Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Group Letter to Biden Administration Regarding Patent Eligibility Reform
-
Group Sign-on Letter to Congress Expressing Concerns about Patent Eligibility Reform Stakeholder Discussions
-
ACMG Letter to Congress Concerning the Verifying Accurate Leading-edge IVCT Development (VALID) Act
-
ACMG Comments to CMS about Proposed Changes to the PFS for CY 2021
-
Group Sign-on Letter to HHS Supporting Clarification of LDT Regulatory Process
-
ACMG Letter to CMS Requesting Reconsideration of Payment Determination for a PALB2 CPT Code 81307
-
ACMG Comments to CMS Regarding CY 2020 CLFS Preliminary Payment Determinations
-
ACMG & ASHG Presidents’ Sign-on Letter to Congress Concerning Patent Eligibility Reform
-
Group Sign-on Letter to Congress Opposing Proposed Amendments to Section 101 of the Patent Act
-
ACMG Comments to Congress Concerning the Verifying Accurate Leading-edge IVCT Development (VALID) Act Discussion Draft